DiscoverStartupsAnagenexAnagenex Funding Rounds, Valuation & Investors
Anagenex company logo
Anagenex
Evolving new drugs using massively parallel biochemistry and machine learning11-50 Employees
  • B2B
  • Growth Stage
    Expanding market presence
  • Top Investors
    This company has received a significant amount of investment from top investors
View 0 jobs

Anagenex Funding

$30M
11 round
Anagenex is active in the following markets / industries: machine learning, artificial intelligence, Drug development and Drug discovery. The company has secured funding across 1 rounds, totaling in an amount of $30M. Their most recent funding was raised on June 8, 2022.

Funding Rounds

A
$30000000
Series AJun 2022$0 valuation
Avatar for Air Street Capital
Avatar for Obvious Ventures
Avatar for Lux Capital
Avatar for Menlo Ventures
+1
Press
Anagenex Closes $30 Million Series A Round led by Catalio to Advance Small Molecule Drug Discovery with a Novel, Directed Evolution Platform

Investors of Anagenex

Air Street Capital
VC Firm • San Francisco
Avatar for Air Street Capital
Air Street Capital invests in AI-first technology and life science companies
Rounds
A
Obvious Ventures
VC Firm • San Francisco
Avatar for Obvious Ventures
Rounds
A
Lux Capital
VC Firm • New York City
Avatar for Lux Capital
Lux helps entrepreneurs turn breakthroughs into world-changing companies
Rounds
A
Menlo Ventures
VC Firm • Menlo Park
Avatar for Menlo Ventures
Seed to growth capital for consumer and enterprise technologies
Rounds
A
Khosla Ventures
VC Firm • Menlo Park
Avatar for Khosla Ventures
We fundamentally like large problems that are amenable to technology solutions
Rounds
A
Back to Culture and benefits
Onwards to Jobs